⚖
Compare Funds
See how two funds stack up side by side, real returns, risk, cost and portfolio overlap.
VS
Key Metrics Comparison
| Metric | SBI MNC Fund - Growth - Direct Plan | HDFC Pharma and Healthcare Fund - Growth - Direct Plan |
|---|---|---|
| Snapshot | ||
| AMC | SBI MF | HDFC MF |
| Category | Equity - Thematic Fund - MNC | Equity - Sectoral Fund - Pharma & Health Care |
| NAV | ₹426.23 (30 Oct 2026) | ₹21.95 (30 Oct 2026) |
| Rating | ★ | ★★★★★ |
| Benchmark | NIFTY MNC - TRI | BSE Health Care - TRI |
| Fund Manager | Tanmaya Desai | Nikhil Mathur |
| Inception | 01 Jan 2013 | 04 Oct 2023 |
| Returns | ||
| 1Y | 8.26% | 22.64% |
| 3Y | 6.69% | 30.41% |
| 5Y | 7.02% | — |
| Since Inception | 14.14% | 29.15% |
| Risk | ||
| 12.72 | 14.07 | |
| 0.65 | 0.59 | |
| 0.10 | 1.59 | |
| -3.31 | 21.67 | |
| 0.20 | 3.48 | |
| -8.45% | -9.23% | |
| Costs | ||
| Expense Ratio | 1.39% | 1.03% |
| Exit Load | 1% on or before 30D, Nil after 30D | 1% on or before 30D, Nil after 30D |
| Min SIP | ₹500 | ₹100 |
| Min Lumpsum | ₹5,000 | ₹100 |
| Lock-in | None | None |
Min SIP is reported per fund, not per plan, every plan of a fund shares the same figure.
Portfolio Overlap
SBI MF86%
HDFC MF86%
14.3%Only 14.3% of holdings by weight are common between SBI MF and HDFC MF, based on each fund's top 20 disclosed holdings, not the full portfolio.
Common holdingSBI MFHDFC MF
Divi's Laboratories Ltd.5.82%9.39%
Sun Pharmaceutical Industries Ltd.3.42%8.28%
Anthem Biosciences Ltd.2.96%3.17%
Cipla Ltd.2.11%4.15%
Category context: Equity vs Equity. Open the full Screener →